Germany · Biotechnology startup

AiCuris

AiCuris is a pharmaceutical company that discovers, researches and develops antiviral and antibacterial agents to treat infectious diseases.

Funding reportedLast round: Series B

BiotechnologyWuppertal, Germany

What company datasets say AiCuris raised

Funding, as reported

Reported in all74.8Min the source's currency
Rounds1
Last roundSeries B
Last round dateApr 2010

Founders and team

From AiCuris's own website: 2 founders, 20 on the team.

Salvia GmbHFounding CEO of Aicuris
Helmut JeggleFounder and Managing Partner
  • Larry EdwardsChief Executive Officer (CEO)
  • Bernadette SurujballyVice President Data Statistics
  • Ilona ArnoldVice President Finance Operations
  • Mark StesneyVice President of Supply Chain
  • Thomas OuelletteVice President Operations
  • Barbara MacgregorProject Director
  • Daniela BoshovenSenior Director Human Resources
  • Emma DelahayDirector Data Management
  • Erica EmondDirector Commercial QA
  • Evgenii BondarenkoDirector Business Development
  • Jeske SminkSenior Director CMC
  • Julian FischerDirector CMC API Manufacturing
  • Matthias KrögerDirector Regulatory Affairs
  • Mehul PunamiyaDirector of Regulatory Affairs
  • Melanie SumnerProject Director
  • Sean MarettSupervisory Board
  • Sean O’SheaDirector Medical Writing
  • Thomas DeszeriDirector IT

And 2 more on the team.

Biotechnology in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put AiCuris in front of investors. Or tell us what we have wrong.